EUVIMEDEUVIMED entdecken
Open Access

CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

Manali Ranade, Sridhar Epari, Omshree Shetty, Sandeep Dhanavade, Sheetal Chavan, Ayushi Sahay, Arpita Sahu, Prakash Shetty, Aliasgar Moiyadi, Vikash Singh, Archya Dasgupta, Abhishek Chatterjee und 2 weitere

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04569-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Manali Ranade und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology (Molecular Pathology Division), Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Astrocytoma, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaBrain NeoplasmsHumansCyclin-Dependent Kinase Inhibitor p16FluorescenceHomozygoteIsocitrate DehydrogenaseMutationSequence DeletionCyclin-Dependent Kinase Inhibitor p15

Stichwörter der Autor:innen

CDKN2A/BIDH-mutantAstrocytomaFluorescence in-situ hybridisation (FISH)

Substanzen

CDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Isocitrate DehydrogenaseCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15

Autor:innen und Institutionen

  • Department of Pathology (Molecular Pathology Division), Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Pathology (Including Molecular Pathology Division), Tata Memorial Hospital & ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. sridhep@gmail.com.
  • Department of Pathology (Including Molecular Pathology Division), Tata Memorial Hospital & ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Radiology, Tata Memorial Hospital & ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Neurosurgical Division of Surgical Oncology, Tata Memorial Hospital & ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Radiation Oncology, Tata Memorial Hospital & ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

Zitieren

APA

Ranade, M., Epari, S., Shetty, O., Dhanavade, S., Chavan, S., Sahay, A., Sahu, A., Shetty, P., Moiyadi, A., Singh, V., Dasgupta, A., Chatterjee, A., Kannan, S., & Gupta, T. (2024). CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04569-7

Vancouver

Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, et al. CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04569-7

BibTeX
@article{Ranade2024,
  author = {Ranade, Manali and Epari, Sridhar and Shetty, Omshree and Dhanavade, Sandeep and Chavan, Sheetal and Sahay, Ayushi and Sahu, Arpita and Shetty, Prakash and Moiyadi, Aliasgar and Singh, Vikash and Dasgupta, Archya and Chatterjee, Abhishek and Kannan, Sadhana and Gupta, Tejpal},
  title = {CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04569-7}
}
Kostenlos starten →